Johnson & Johnson stock outperforms market despite losses on the day


Shares of Johnson & Johnson
JNJ,

sank 0.44% to $167.10 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index
SPX,

falling 1.84% to 4,577.11 and Dow Jones Industrial Average
DJIA,

falling 1.51% to 35,368.47. This was the stock’s sixth consecutive day of losses. Johnson & Johnson closed $12.82 below its 52-week high ($179.92), which the company achieved on August 20th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert.
RHHVF,

fell 0.52% to $395.45, Merck & Co. Inc.
MRK,

rose 0.20% to $81.54, and Pfizer Inc.
PFE,

fell 1.53% to $54.11. Trading volume (7.3 M) remained 135,653 below its 50-day average volume of 7.5 M.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.



Read More: Johnson & Johnson stock outperforms market despite losses on the day

article_normalC&E Industry News FilterContent TypescorporateCorporate/Industrial NewsDayFactiva FiltersFinancial PerformanceHealthcareHealthcare/Life Sciencesindustrial newsJNJJohnsonjohnson & johnsonlife sciencesLossesmarketoutperformsPharmaceuticalsstock
Comments (0)
Add Comment